Last 47 quarters of trend data · Technology · Information Technology Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Dolby Laboratories, Inc.'s quarterly P/E stands at 29.9x, up 6.6% year-over-year.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 19.97 | 29.87 | 35.49 | 38.57 | 21.25 | 28.03 | 30.99 | 49.52 | 20.74 | 31.22 | 220.17 | 123.06 | 21.79 |
| — | +6.6% | +14.5% | -22.1% | +2.5% | -10.2% | -85.9% | -59.8% | -4.8% | +45.2% | +278.5% | +171.1% | -60.3% | |
| P/S Ratio | 3.71 | 4.57 | 5.71 | 5.68 | 5.27 | 5.34 | 5.99 | 6.65 | 5.56 | 6.65 | 6.66 | 6.83 | 5.53 |
| — | -14.3% | -4.7% | -14.5% | -5.3% | -19.7% | -10.1% | -2.7% | +0.7% | +30.2% | +15.6% | +10.1% | -9.0% | |
| P/B Ratio | 1.94 | 2.44 | 2.66 | 2.74 | 3.02 | 3.03 | 2.94 | 3.14 | 3.33 | 3.55 | 3.26 | 3.42 | 3.53 |
| — | -19.6% | -9.3% | -12.6% | -9.4% | -14.8% | -10.0% | -8.3% | -5.6% | +19.0% | +14.5% | +17.1% | +13.1% | |
| P/FCF | 11.62 | 32.08 | 17.35 | 29.28 | 11.59 | 19.06 | 16.78 | 140.69 | 11.76 | 908.80 | 25.19 | 17.93 | 21.42 |
| — | +68.3% | +3.4% | -79.2% | -1.4% | -97.9% | -33.4% | +684.7% | -45.1% | +2511.4% | -36.2% | +61.1% | -45.9% | |
| EV / EBITDA | 11.93 | 16.13 | 29.25 | 22.61 | 12.97 | 16.00 | 24.38 | 28.02 | 14.42 | 20.73 | 33.95 | 32.53 | 14.32 |
| — | +0.8% | +20.0% | -19.3% | -10.0% | -22.9% | -28.2% | -13.9% | +0.7% | +53.9% | +26.2% | +50.6% | -41.1% | |
| EV / EBIT | 16.37 | 18.95 | 44.32 | 34.59 | 15.81 | 20.73 | 28.34 | 34.67 | 15.07 | 23.93 | 193.03 | 77.94 | 16.34 |
| — | -8.6% | +56.4% | -0.2% | +4.8% | -13.3% | -85.3% | -55.5% | -7.7% | +52.8% | +309.7% | +141.5% | -61.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Dolby Laboratories, Inc.'s operating margin was 17.9% in Q1 2026, up 8.3 pp QoQ and down 5.9 pp YoY.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 88.1% | 87.5% | 87.1% | 86.1% | 90.3% | 88.6% | 88.8% | 87.7% | 89.4% | 89.8% | 87.8% | 86.1% | 89.1% |
| — | -1.2% | -1.9% | -1.8% | +1.1% | -1.4% | +1.2% | +1.8% | +0.3% | +0.1% | +1.3% | -1.7% | -0.3% | |
| Operating Margin | 19.6% | 17.9% | 9.7% | 15.1% | 30.3% | 23.8% | 14.8% | 14.1% | 29.2% | 22.9% | 9.3% | 10.9% | 29.1% |
| — | -24.8% | -34.6% | +6.7% | +3.7% | +4.0% | +58.5% | +29.4% | +0.5% | -18.2% | -18.1% | -32.0% | +100.3% | |
| Net Margin | 18.9% | 15.4% | 16.1% | 14.6% | 24.8% | 19.0% | 19.2% | 13.3% | 26.8% | 21.2% | 3.2% | 5.5% | 25.5% |
| — | -19.0% | -16.4% | +9.7% | -7.4% | -10.5% | +507.8% | +142.2% | +5.4% | -10.4% | -68.3% | -59.8% | +131.8% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.0% | 2.0% | 1.9% | 1.8% | 3.6% | 2.7% | 2.4% | 1.6% | 4.1% | 2.8% | 0.4% | 0.7% | 4.1% |
| — | -24.8% | -20.8% | +12.6% | -11.7% | -4.2% | +514.4% | +127.4% | -1.0% | -19.0% | -67.2% | -55.7% | +194.2% | |
| ROA | 8.0% | 1.7% | 1.5% | 1.4% | 2.9% | 2.2% | 1.9% | 1.3% | 3.3% | 2.3% | 0.3% | 0.6% | 3.4% |
| — | -23.0% | -20.0% | +12.2% | -12.2% | -4.5% | +526.9% | +127.7% | -4.5% | -22.4% | -69.0% | -57.6% | +187.8% | |
| ROIC | 10.1% | 2.3% | 1.1% | 1.9% | 4.4% | 3.3% | 1.8% | 1.8% | 4.7% | 3.3% | 1.3% | 1.5% | 4.8% |
| — | -28.1% | -38.3% | +3.1% | -7.4% | -0.4% | +46.4% | +23.7% | -1.0% | -21.2% | -12.2% | -28.5% | +124.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Dolby Laboratories, Inc.'s Debt/EBITDA ratio is 0.5x, down from 0.7x last quarter — comfortably within a safe range. The current ratio has improved 9.1% YoY to 3.17x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| — | -11.6% | -21.8% | -24.0% | -26.5% | -11.7% | -11.5% | -6.3% | +4.8% | -3.3% | -5.7% | -11.8% | -16.8% | |
| Debt / EBITDA | 0.11 | 0.46 | 0.72 | 0.54 | 0.30 | 0.40 | 0.68 | 0.78 | 0.41 | 0.51 | 0.99 | 0.88 | 0.36 |
| — | +13.3% | +5.9% | -30.1% | -27.3% | -20.4% | -31.4% | -11.7% | +14.1% | +24.1% | +5.0% | +10.8% | -57.9% | |
| Current Ratio | 3.17 | 3.17 | 3.17 | 3.44 | 3.04 | 2.91 | 2.86 | 4.14 | 3.50 | 3.68 | 3.52 | 3.47 | 4.66 |
| — | +9.1% | +10.9% | -16.9% | -13.3% | -21.0% | -18.9% | +19.3% | -24.8% | -20.7% | -25.4% | -34.1% | -19.3% | |
| Quick Ratio | 3.10 | 3.10 | 3.10 | 3.36 | 2.96 | 2.84 | 2.78 | 4.04 | 3.42 | 3.59 | 3.44 | 3.40 | 4.56 |
| — | +9.4% | +11.7% | -17.0% | -13.5% | -20.9% | -19.2% | +19.1% | -25.0% | -21.3% | -25.9% | -34.5% | -20.2% | |
| Interest Coverage | — | 18.39 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DLB stock.
Dolby Laboratories, Inc.'s current P/E is 20.0x. The average P/E over the last 4 quarters is 31.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Dolby Laboratories, Inc.'s current operating margin is 19.6%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Dolby Laboratories, Inc.'s business trajectory between earnings reports.